|
ZBTB41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.239800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.642300E-03 |
| Normal-vs-Stage2 |
5.148800E-01 |
| Normal-vs-Stage3 |
5.623800E-01 |
| Normal-vs-Stage4 |
8.106400E-01 |
| Stage1-vs-Stage2 |
3.281800E-01 |
| Stage1-vs-Stage3 |
5.421700E-02 |
| Stage1-vs-Stage4 |
1.220030E-01 |
| Stage2-vs-Stage3 |
3.764800E-01 |
| Stage2-vs-Stage4 |
5.389000E-01 |
| Stage3-vs-Stage4 |
8.869800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.586400E-02 |
| Normal-vs-AfricanAmerican |
3.597600E-02 |
| Normal-vs-Asian |
1.160580E-01 |
| Caucasian-vs-AfricanAmerican |
5.210800E-01 |
| Caucasian-vs-Asian |
7.046000E-01 |
| AfricanAmerican-vs-Asian |
8.654000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.119300E-03 |
| Normal-vs-Female |
6.575800E-01 |
| Male-vs-Female |
8.296500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.415200E-01 |
| Normal-vs-Extreme_Weight |
2.847200E-04 |
| Normal-vs-Obese |
5.051000E-01 |
| Normal-vs-Extreme_Obese |
6.991800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.494440E-01 |
| Normal_Weight-vs-Obese |
7.236600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.615000E-01 |
| Extreme_Weight-vs-Obese |
2.806200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.822630E-01 |
| Obese-vs-Extreme_Obese |
9.765400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.637400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.413600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.379100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.160110E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.912560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.466400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.064300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.386500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.334200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.525000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.959400E-03 |
| Normal-VS-Type2 PRCC |
3.756800E-01 |
| Normal-VS-KIRP CIMP |
2.553400E-01 |
| Normal-VS-Unclassified PRCC |
6.325600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.459800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.364100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.534980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.630100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.091000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.050040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.526000E-02 |
| Normal-vs-N1 |
1.548840E-01 |
| Normal-vs-N2 |
7.565000E-01 |
| N0-vs-N1 |
1.990500E-02 |
| N0-vs-N2 |
5.633600E-01 |
| N1-vs-N2 |
4.856200E-01 |
|
|
